Dresden-based anvajo, a technology company that develops, manufactures and sells innovative solutions for analysing liquids, announced that it has raised €17.7M in a Series A round of funding to support “the launch into the human medicine markets.”
The investment came from pharmaceutical company MEDICE Arzneimittel Pütter GmbH & Co. KG, the Johnsonville Holdings, Inc. fund, and German diagnostics specialists Elber Beteiligungen and Think.Health. Besides, Die BrückenköpfeX also participated in the round.
Stefan Fraedrich founded anvajo and is currently led by CEO Felix Lambrecht. It is a spin-off diagnostic company from Dresden University of Technology and is a developer and manufacturer of point-of-care solutions for the diagnostic testing of liquids.
RELATED: Implanet announces the success of its capital increase
The anvajo team has created a portable tool for point-of-care fluid analysis that has the potential to be employed in a range of sectors. The company says, “Our team is working on the world’s most compact universal platform for fluid analysis, the “fluidlab.” It combines the instrument itself, a software suite and multifunctional sample carriers.”
The “fluidlab” combines two central laboratory technologies, Spectroscopy and Microscopy, in one portable diagnostic device. The performance of each test is supported by a custom-designed sample carrier system that functions in processing and delivering the fluid to the analyser.
Follow the latest news on Guided Solutions
